Related Experiment Video

Updated: Jun 21, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Current and future methods for evaluating the allergenic potential of proteins: international workshop

James E Gibson1

  • 1East Carolina University, Pharmacology and Toxicology, Greenville 27834, USA. gibsonj@mail.ecu.edu

Regulatory Toxicology and Pharmacology : RTP
|July 21, 2009
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Allergic Reactions02:06

Allergic Reactions

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

Articles linked to this work by shared authors, journal, and citation graph.

Marine brevetoxin induces IgE-independent mast cell activation.

Archives of toxicology·2010

Brevetoxin 2 alters expression of apoptotic, DNA damage, and cytokine genes in Jurkat cells.

Human & experimental toxicology·2010

Brevetoxins 2, 3, 6, and 9 show variability in potency and cause significant induction of DNA damage and apoptosis in Jurkat E6-1 cells.

Archives of toxicology·2009

Glycoalkaloid responses of potato to Colorado potato beetle defoliation.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2008

The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes.

Archives of toxicology·2005

Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?

The Journal of pharmacology and experimental therapeutics·2005

Toxicological Assessment of Potential Leachables in Parenteral Drug Products: Bioavailability Adjustment Considerations.

Regulatory toxicology and pharmacology : RTP·2026

New approach methodologies in food safety: A survey and commentary on industry adoption, barriers, and the path to regulatory adoption.

Regulatory toxicology and pharmacology : RTP·2026

Phototoxic evaluation of agrochemicals by a newly developed in vitro UVB-induced phototoxicity test using human embryonic stem cell- or induced pluripotent stem cell-derived retinal pigment epithelial cells.

Regulatory toxicology and pharmacology : RTP·2026

Overcoming Difficult, Impossible, and Meaningless Animal Testing under REACH: Opportunities for Robust Chemical Risk Assessment with Non-Animal Approaches.

Regulatory toxicology and pharmacology : RTP·2026

An evaluation of the use of the Universal Benefit-Risk Assessment Framework by the Zambia Medicines Regulatory Authority for documenting and communicating benefit-risk decisions.

Regulatory toxicology and pharmacology : RTP·2026

Standardization and assessment of acute dermal toxicity of an Ayurvedic medicine Brihat Somraji Taila in Sprague-Dawley rats.

Regulatory toxicology and pharmacology : RTP·2026

Malar rash in systemic lupus erythematosus: clinical, serological, and therapeutic associations in a single-center retrospective study of 1039 patients.

Polish archives of internal medicine·2026

Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Acta dermato-venereologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us